Interval Partners LP Lowers Holdings in CME Group Inc. (NASDAQ:CME)

Interval Partners LP lowered its holdings in CME Group Inc. (NASDAQ:CME) by 8.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 53,250 shares of the financial services provider’s stock after selling 4,961 shares during the quarter. Interval Partners LP’s holdings in CME Group were worth $12,366,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Norges Bank acquired a new position in CME Group in the fourth quarter valued at about $1,107,389,000. Price T Rowe Associates Inc. MD lifted its holdings in shares of CME Group by 89.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider’s stock worth $1,923,047,000 after acquiring an additional 3,921,278 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of CME Group in the 4th quarter worth approximately $871,063,000. Capital Wealth Planning LLC boosted its position in shares of CME Group by 69.2% during the 4th quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider’s stock worth $565,671,000 after purchasing an additional 996,498 shares during the period. Finally, Egerton Capital UK LLP acquired a new stake in CME Group in the 4th quarter valued at approximately $223,967,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Up 0.8 %

CME Group stock opened at $284.35 on Friday. The stock has a market cap of $102.47 billion, a PE ratio of 29.41, a P/E/G ratio of 6.76 and a beta of 0.45. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The stock’s fifty day moving average is $264.47 and its two-hundred day moving average is $245.67. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $286.48.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. The business had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The business’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the company earned $2.50 EPS. On average, sell-side analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.76%. The ex-dividend date is Monday, June 9th. CME Group’s payout ratio is 50.30%.

Insider Activity at CME Group

In other CME Group news, insider Derek Sammann sold 4,650 shares of CME Group stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the transaction, the insider now owns 8,336 shares of the company’s stock, valued at $2,339,164.96. The trade was a 35.81 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Dennis Suskind sold 1,000 shares of the stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total value of $271,280.00. Following the completion of the sale, the director now directly owns 2,915 shares of the company’s stock, valued at $790,781.20. The trade was a 25.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 34,726 shares of company stock valued at $8,975,813 in the last ninety days. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on CME. Piper Sandler upped their price target on CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 8th. UBS Group increased their target price on CME Group from $290.00 to $305.00 and gave the stock a “buy” rating in a research note on Friday, April 25th. Morgan Stanley lifted their target price on CME Group from $301.00 to $304.00 and gave the company an “overweight” rating in a research report on Thursday, April 24th. Bank of America increased their price target on shares of CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a research report on Wednesday, April 2nd. Finally, Oppenheimer raised their price objective on shares of CME Group from $269.00 to $279.00 and gave the company an “outperform” rating in a research note on Friday, April 11th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, CME Group has a consensus rating of “Hold” and an average target price of $256.80.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.